# A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension

> **NCT06216808** · NA · RECRUITING · sponsor: **DeepQure Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Resistant Hypertension

## Interventions

- **DEVICE:** HyperQure Renal Denervation System

## Key facts

- **NCT ID:** NCT06216808
- **Lead sponsor:** DeepQure Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-04
- **Primary completion:** 2026-03-06
- **Final completion:** 2026-12-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06216808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06216808, "A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06216808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*